Cargando…

Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?

Detalles Bibliográficos
Autores principales:	Chandiramani, Rishi, Cao, Davide, Mehran, Roxana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214884/ https://www.ncbi.nlm.nih.gov/pubmed/32411779 http://dx.doi.org/10.21037/atm.2020.01.28

Ejemplares similares

Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial
por: Zilberszac, Robert, et al.
Publicado: (2019)

Influence of Stent Length on Periprocedural Outcomes After Primary Percutaneous Coronary Intervention in Patients with ST Segment Elevation Myocardial Infarction
por: Chen, Yan, et al.
Publicado: (2022)

Staged versus One-Time Percutaneous Coronary Intervention Strategy for Multivessel Non-ST Segment Elevation Acute Coronary Syndrome
por: Kim, Yun Gi, et al.
Publicado: (2016)

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018)

Diffuse ST-segment elevation beyond acute coronary syndrome
por: Zhu, Hai, et al.
Publicado: (2023)

Pharmaco-invasive strategy: An attractive alternative for management of ST-elevation myocardial infarction when timely primary percutaneous coronary intervention is not feasible
por: Sharma, V
Publicado: (2018)

Desperate Times, Desperate Measures: Same-Day Discharge for ST Segment Elevation Myocardial Infarction Patients
por: Riaz, Haris
Publicado: (2022)

Anemia and Acute Coronary Syndrome: Time for Intervention Studies
por: Farhan, Serdar, et al.
Publicado: (2016)

ST Segment Elevation with Normal Coronaries
por: Sethi, Pooja, et al.
Publicado: (2016)

Targeting an Ischemic Time <120 Minutes in ST‐Segment–Elevation Myocardial Infarction
por: Henderson, Matthew, et al.
Publicado: (2019)

Hyphema: A Rare Complication of Periprocedural Antiplatelets and Anticoagulants Following Percutaneous Coronary Intervention
por: Gulati, Amit, et al.
Publicado: (2021)

Risk Factors of Periprocedural Bradycardia during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction
por: Li, Yong, et al.
Publicado: (2019)

It is time to focus on pre-hospital delays in patients with ST-segment elevation myocardial infarction
por: Kim, Hack-Lyoung
Publicado: (2020)

Pharmacological protection of reperfusion injury in ST-segment elevation myocardial infarction. Gone with the wind?
por: Tonet, Elisabetta, et al.
Publicado: (2018)

False Positive ST-Segment Elevation Myocardial Infarction
por: Jeong, Hae Chang, et al.
Publicado: (2013)

ST-segment elevation myocardial infarction hospitalisations remain unchanged during COVID-19
por: Koo, Chieh Yang, et al.
Publicado: (2020)

ANMCO POSITION PAPER: Timing of coronary angiography in non-ST-segment elevation acute coronary syndromes
por: Murrone, Adriano, et al.
Publicado: (2021)

Fourth universal definition of myocardial infarction. Selected messages from the European Society of Cardiology document and lessons learned from the new guidelines on ST-segment elevation myocardial infarction and non-ST-segment elevation-acute coronary syndrome
por: Domienik-Karłowicz, Justyna, et al.
Publicado: (2021)

Commentary: Data and COVID-19-associated mucormycosis: Time to pause and reassess?
por: Nair, Akshay Gopinathan
Publicado: (2022)

Mechanical complications of ST segment elevation myocardial infarction: are they tangible?
por: Choi, Seong Huan, et al.
Publicado: (2022)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland
por: Boeddinghaus, Jasper, et al.
Publicado: (2020)

The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: early invasive strategy for all?
por: Arslan, F., et al.
Publicado: (2017)

Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non–ST‐Segment–Elevation Myocardial Infarction
por: Majmundar, Monil, et al.
Publicado: (2022)

Operator-patient sex discordance and periprocedural outcomes of percutaneous coronary intervention (from the ORPKI Polish National Registry)
por: Dziewierz, Artur, et al.
Publicado: (2023)

Treatment of acute coronary syndrome without ST-segment elevations in the elderly
por: Oliveira, GMM, et al.
Publicado: (2005)

ST-Segment Elevation in the Setting of Diabetic Ketoacidosis: Is It Acute Coronary Syndrome?
por: Wray, Jesse, et al.
Publicado: (2020)

Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)
por: Dziewierz, Artur, et al.
Publicado: (2022)

Tracking global resources and capacity for health research: time to reassess strategies and investment decisions
por: Adam, Taghreed, et al.
Publicado: (2023)

Reassessing After-Hour Arrival Patterns and Outcomes in ST-Elevation Myocardial Infarction
por: Langabeer, James, et al.
Publicado: (2015)

The Operator Volume of Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction Does Not Guarantee Its Quality in Korea
por: Yoon, Chang-Hwan
Publicado: (2019)

Risk stratification vs routine intensive care stay in non ST segment elevation myocardial infarction (NSTEMI)
por: Savonitto, Stefano, et al.
Publicado: (2020)

Prognostic Impact of Early ST-Segment Resolution and Biochemical Markers in Patients With ST-Elevation Myocardial Infarction
por: Chung, Ick-Mo
Publicado: (2011)

Uptake and Utilization of the Management of Anticoagulation in the Periprocedural Period App: Longitudinal Analysis
por: Spyropoulos, Alex C, et al.
Publicado: (2018)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
por: Minhas, Abdul Mannan Khan, et al.
Publicado: (2017)

Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
por: Lee, Jeffrey, et al.
Publicado: (2022)

Reassessing the role of NAD as a prosurvival factor
por: Preyat, Nicolas, et al.
Publicado: (2015)

Embryoid research calls for reassessment of legal regulations
por: Hengstschläger, Markus, et al.
Publicado: (2021)

Reassessing assumptions about the evolution of herbivore teeth
por: Sanson, Gordon D.
Publicado: (2023)

COVID-19 management: Opportunity to reassess protocols?
por: Sodhi, Jitender, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0itcd8ihf226145d1vmqhrpsba